Much of Boost Run's contracted revenue will be accumulated in the future; with this deal, the company's total TCV now tops $2 ...

Separately, the company's equity was the focus of a new analyst note, and a positive one at that. StoneX analyst Yi Fu Lee ...

After market close on Monday, S&P Dow Jones Indices announced that Freshworks is to replace healthcare stock BioLife ...

The jury awarded Aerosonic $68.6 million for the NDA breach, $29.9 million to cover Aerosonic's losses and Joby's gains from ...

The three best-performing stocks on the S&P 500 this year have been Sandisk ( SNDK -2.73%), Moderna ( MRNA -7.20%), and Dell ...

Because it is a monopoly, AMSL typically carries a very high multiple. For 2030, analysts project EPS of $101.57, and if we ...

Delivery and ridesharing services provider Grab Holdings ( GRAB -3.15%) didn't provide its investors with much of a lift in ...

SpaceX trades at a lofty valuation, even if you account for its projected $100 billion in annual recurring revenue. These ...

We've already established that Verizon pays a higher dividend yield, trades at a lower valuation, and operates at higher ...

Two analysts raised their price targets on the electronic components maker.

On Sept. 10, HSBC analyst Rajesh Kumar maintained his "buy" rating on AbbVie ( ABBV +0.53%), raising his price target on the ...

Many investors initially thought the Paramount-Warner Bros. Discovery merger would struggle to get over the finish line due ...